Earnings Call · Q2 FY2021·2021-10-25

Q2 21EPS -11.43%·Rev n/aQ1 21EPS -34.29%·Rev n/aQ4 20EPS +20.69%·Rev n/aQ3 20EPS +13.33%·Rev n/a⚠ consensus missing

PETMED EXPRESS INC PETS

Bruce Rosenbloom — CFO (Chief Financial Officer) or similar financial executive, based on reviewing financial results and answering margin questions

Matthew Hulett — CEO (Chief Executive Officer)

Unknown — Executive or Senior Management (likely CFO or similar) based on context of discussing earnings and investment fundamentals

−7.2%1d on move date−6.7% vs SPY3d0.0%5d+4.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PETS calls or request research access.

More PETS calls Browse calls Request research access